PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.06%
Net income growth 1.25-1.5x TSM's 6.31%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
-4.01%
Negative yoy D&A while TSM is 3.40%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-209.43%
Negative yoy deferred tax while TSM stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
8.88%
SBC growth while TSM is negative at -31.22%. John Neff would see competitor possibly controlling share issuance more tightly.
112.65%
Well above TSM's 23.03% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
125.27%
AR growth while TSM is negative at -25.04%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-259.14%
Negative yoy inventory while TSM is 7.85%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-66.67%
Negative yoy AP while TSM is 140.80%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
164.15%
Growth well above TSM's 39.27%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-950.00%
Negative yoy while TSM is 94.14%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
61.61%
Operating cash flow growth above 1.5x TSM's 18.67%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
40.17%
Some CapEx rise while TSM is negative at -24.87%. John Neff would see competitor possibly building capacity while we hold back expansions.
102.51%
Less M&A spending yoy vs. TSM's 5281.96%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
-42.78%
Both yoy lines negative, with TSM at -46.49%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-16.54%
We reduce yoy sales while TSM is 5.54%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
80.57%
We have some outflow growth while TSM is negative at -155.27%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-56.37%
Both yoy lines negative, with TSM at -38.60%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
24.16%
Buyback growth of 24.16% while TSM is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.